(Q39693736)

English

The activity of the lipophilic nucleoside derivatives elacytarabine and CP-4126 in a panel of tumor cell lines resistant to nucleoside analogues

scientific article published on June 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

The activity of the lipophilic nucleoside derivatives elacytarabine and CP-4126 in a panel of tumor cell lines resistant to nucleoside analogues (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

author name string

Marit Liland Sandvold

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Carlos Galmarini

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Finn Myhren

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Godefridus Peters

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

publication date

1 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Nucleosides, Nucleotides & Nucleic Acids

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

4-6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

386-393

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Nucleoside analogues: mechanisms of drug resistance and reversal strategies.

1 reference

https://api.crossref.org/works/10.1080%2F15257771003729625

21 January 2018

Antiproliferative activity and mechanism of action of fatty acid derivatives of gemcitabine in leukemia and solid tumor cell lines and in human xenografts.

1 reference

https://api.crossref.org/works/10.1080%2F15257771003729625

21 January 2018

Intravenous administration of CP-4055 (ELACYT) in patients with solid tumours. A Phase I study

1 reference

https://api.crossref.org/works/10.1080%2F15257771003729625

21 January 2018

CP-4055 and CP-4126 are active in ara-C and gemcitabine-resistant lymphoma cell lines

1 reference

https://api.crossref.org/works/10.1080%2F15257771003729625

21 January 2018

In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant

1 reference

https://api.crossref.org/works/10.1080%2F15257771003729625

21 January 2018

Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cells.

1 reference

https://api.crossref.org/works/10.1080%2F15257771003729625

21 January 2018

Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells

1 reference

https://api.crossref.org/works/10.1080%2F15257771003729625

21 January 2018

Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine.

1 reference

https://api.crossref.org/works/10.1080%2F15257771003729625

21 January 2018

Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1080%2F15257771003729625

21 January 2018

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1080%2F15257771003729625

21 January 2018

Immunocytochemical detection of hENT1 and hCNT1 in normal tissues, lung cancer cell lines, and NSCLC patient samples

1 reference

https://api.crossref.org/works/10.1080%2F15257771003729625

21 January 2018

Cytosine arabinoside influx and nucleoside transport sites in acute leukemia

1 reference

https://api.crossref.org/works/10.1080%2F15257771003729625

21 January 2018

The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1080%2F15257771003729625

21 January 2018

Platinum resistance: the role of DNA repair pathways

1 reference

https://api.crossref.org/works/10.1080%2F15257771003729625

21 January 2018

Mismatched nucleotides as the lesions responsible for radiosensitization with gemcitabine: a new paradigm for antimetabolite radiosensitizers

1 reference

https://api.crossref.org/works/10.1080%2F15257771003729625

21 January 2018

Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1080%2F15257771003729625

21 January 2018

Identifiers

10.1080/15257771003729625

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39693736&oldid=2088869696"